send to a friend by email

Jerusalem Pharmaceuticals Company achieves pretax income of JD0.56 million in Q1 2013

2013-05-01

According to Jerusalem Pharmaceuticals Company ( JPH)’s  data for the first three months of the year, net profit before tax reached 561,828 JOD, compared with a net loss of (219,585) JOD from the first three months of 2012. Total assets of the company reached 35,760,807 JOD as of March 31^st, 2013, compared to total assets of 34,652,743 JOD as of December 31^st, 2012, a net increase of 3.2%. Total liabilities of the company reached 11,787,956 JOD as of March 31^st, 2013, compared to total liabilities of 10,751,846 JOD as of December 31^st, 2012, a net increase of 9.6%. Net ownership equity of the company reached 23,972,851 JOD (including 640,866 JOD in Non-controlling interest) as of March 31^st, 2013, compared with a net ownership equity of 23,900,897 JOD (including 674,614 JOD in Non-controlling interest) as of December 31^st, 2012, a net increase of 0.3% in the first three months.